Parallel Advisors’s Healthpeak Properties DOC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $204K | Buy |
12,418
+3,257
| +36% | +$55.8K | ﹤0.01% | 1160 |
|
|
2025
Q4 | $147K | Sell |
9,161
-2,943
| -24% | -$51.9K | ﹤0.01% | 1245 |
|
|
2025
Q3 | $232K | Sell |
12,104
-3,091
| -20% | -$55.4K | ﹤0.01% | 984 |
|
|
2025
Q2 | $266K | Buy |
15,195
+1,215
| +9% | +$21.6K | 0.01% | 879 |
|
|
2025
Q1 | $283K | Buy |
13,980
+561
| +4% | +$11.3K | 0.01% | 810 |
|
|
2024
Q4 | $272K | Sell |
13,419
-622
| -4% | -$13.5K | 0.01% | 803 |
|
|
2024
Q3 | $321K | Buy |
14,041
+1,614
| +13% | +$34.8K | 0.01% | 735 |
|
|
2024
Q2 | $244K | Buy |
12,427
+777
| +7% | +$14.8K | 0.01% | 788 |
|
|
2024
Q1 | $218K | Buy |
11,650
+1,173
| +11% | +$21.3K | 0.01% | 821 |
|
|
2023
Q4 | $207K | Buy |
10,477
+4,602
| +78% | +$81K | 0.01% | 784 |
|
|
2023
Q3 | $108K | Sell |
5,875
-12
| -0.2% | -$246 | ﹤0.01% | 1050 |
|
|
2023
Q2 | $118K | Buy |
5,887
+1,053
| +22% | +$21.9K | ﹤0.01% | 999 |
|
|
2023
Q1 | $106K | Buy |
4,834
+1,646
| +52% | +$40.8K | ﹤0.01% | 1027 |
|
|
2022
Q4 | $79.9K | Buy |
3,188
+1,275
| +67% | +$31K | ﹤0.01% | 1081 |
|
|
2022
Q3 | $44K | Buy |
1,913
+40
| +2% | +$1.06K | ﹤0.01% | 1320 |
|
|
2022
Q2 | $49K | Buy |
1,873
+170
| +10% | +$5.15K | ﹤0.01% | 1262 |
|
|
2022
Q1 | $59K | Sell |
1,703
-1,076
| -39% | -$36.2K | ﹤0.01% | 1213 |
|
|
2021
Q4 | $100K | Buy |
2,779
+72
| +3% | +$2.48K | ﹤0.01% | 1010 |
|
|
2021
Q3 | $91K | Buy |
2,707
+498
| +23% | +$17.6K | ﹤0.01% | 1020 |
|
|
2021
Q2 | $74K | Buy |
2,209
+427
| +24% | +$14.3K | ﹤0.01% | 1051 |
|
|
2021
Q1 | $57K | Buy |
1,782
+89
| +5% | +$2.7K | ﹤0.01% | 1119 |
|
|
2020
Q4 | $51K | Sell |
1,693
-1,125
| -40% | -$32.7K | ﹤0.01% | 1085 |
|
|
2020
Q3 | $76K | Sell |
2,818
-1,132
| -29% | -$31K | ﹤0.01% | 885 |
|
|
2020
Q2 | $108K | Sell |
3,950
-649
| -14% | -$16.6K | 0.01% | 735 |
|
|
2020
Q1 | $109K | Buy |
4,599
+3,058
| +198% | +$99.7K | 0.01% | 648 |
|
|
2019
Q4 | $53K | Buy |
1,541
+177
| +13% | +$6.19K | ﹤0.01% | 1014 |
|
|
2019
Q3 | $49K | Buy |
1,364
+314
| +30% | +$10.6K | ﹤0.01% | 993 |
|
|
2019
Q2 | $34K | Sell |
1,050
-138
| -12% | -$4.29K | ﹤0.01% | 1050 |
|
|
2019
Q1 | $37K | Buy |
1,188
+117
| +11% | +$3.56K | ﹤0.01% | 958 |
|
|
2018
Q4 | $29K | Hold |
1,071
| – | – | ﹤0.01% | 936 |
|
|
2018
Q3 | $28K | Buy |
1,071
+2
| +0.2% | +$53 | ﹤0.01% | 1015 |
|
|
2018
Q2 | $27K | Sell |
1,069
-885
| -45% | -$20.9K | ﹤0.01% | 935 |
|
|
2018
Q1 | $45K | Buy |
1,954
+1,309
| +203% | +$30.4K | 0.01% | 728 |
|
|
2017
Q4 | $17K | Sell |
645
-28
| -4% | -$742 | ﹤0.01% | 1077 |
|
|
2017
Q3 | $18K | Sell |
673
-778
| -54% | -$23.4K | ﹤0.01% | 1037 |
|
|
2017
Q2 | $46K | Buy |
1,451
+392
| +37% | +$12.4K | 0.01% | 708 |
|
|
2017
Q1 | $32K | Buy |
1,059
+975
| +1,161% | +$29.9K | 0.01% | 787 |
|
|
2016
Q4 | $2K | Buy |
+84
| New | +$2.56K | ﹤0.01% | 1611 |
|
Other funds holding DOC
VPM
VCM
DAM
Parallel Advisors's DOC Position: Q1 2026 in Review
Parallel Advisors increased its Healthpeak Properties (DOC) stake by 36% in Q1 2026, buying an estimated $55.8K and bringing the position to 12,418 shares worth $204K. The position accounts for ﹤0.01% of the portfolio, ranked #1160.
Parallel Advisors first reported a position in DOC in Q4 2016 and has held it in 38 quarters since. The position peaked at $321K in Q3 2024. 756 funds tracked by Wall St. Rank hold DOC as of Q1 2026.
- Parallel Advisors held 12,418 shares of Healthpeak Properties worth $204K as of Q1 2026.
- Parallel Advisors bought 3,257 Healthpeak Properties shares in Q1 2026, an estimated $55.8K.
- Healthpeak Properties made up ﹤0.01% of Parallel Advisors's portfolio in Q1 2026, its #1160 holding.
- Parallel Advisors first reported a position in Healthpeak Properties in Q4 2016 and has held it in 38 quarters since.
- Parallel Advisors's Healthpeak Properties position peaked at $321K in Q3 2024.
- 756 funds tracked by Wall St. Rank held Healthpeak Properties as of Q1 2026.
Based on Parallel Advisors's 13F filing for Q1 2026, filed 7 May 2026.